Boehringer Ingelheim Pharma GmbH and Co. KG
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Birkendorfer Strasse 65, Biberach an der Riss, 88397, Germany (DEU)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3002806518 · DUNS 340700520
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-07-22
- VAIDrug Quality Assurance2019-09-19
- NAIBioresearch Monitoring2019-08-15
- VAIDrug Quality Assurance2019-04-05
- VAIDrug Quality Assurance2014-05-30
- NAIDrug Quality Assurance2013-03-19
- VAIDrug Quality Assurance2012-03-13
- VAIDrug Quality Assurance2010-05-26
- NAIDrug Quality Assurance2010-01-28
- VAIDrug Quality Assurance2009-05-19
Drugs this plant is listed as making
7 distinct drugs across 12 products name this site in their FDA label.
- aldesleukinIovance Biotherapeutics, Inc
- AlemtuzumabGenzyme Corporation
- anakinraSwedish Orphan Biovitrum AB (publ)
- idarucizumabBoehringer Ingelheim Pharmaceuticals, Inc.
- interferon beta-1bBayer HealthCare Pharmaceuticals Inc.
- spesolimabLEO Pharma Inc.
- spesolimab-sbzoBoehringer Ingelheim Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.